An expert explained the role oncology nurses and advanced practice providers play in caring for patients with sarcoma during ...

TiumBio has dosed the first subject in its Phase II clinical trial of an oral immuno-oncology drug, TU2218, targeting ...

Mural Oncology a clinical-stage oncology company focused on discovering and developing immunotherapies, held its first ...

Teva Pharmaceuticals International and mAbxience have entered into a worldwide licencing agreement to develop an anti ...

Aktis Oncology, a clinical-stage biotechnology company, has announced the successful closure of a $175m Series B financing ...

Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid ...

IGM Biosciences announces strategic pivot to focus on autoimmunity, reducing spending on oncology research, and extending ...

An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration ...

Integrated Oncology Network, a radiation oncology management and cancer center development company based in Corona del Mar, ...

The Rome Study demonstrated the value of extensive sequencing and discussion of individual cancer cases to offer tailored therapeutic choices.

Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate GlobeNewswire October ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...